Xiao Qing, Li Xue, Sun Deming, Yi Huanfa, Lu Xiaoxiao, Nian Hong
Tianjin Medical University Eye Hospital, Eye Institute and School of Optometry and Ophthalmology, Tianjin 300384, China.
Doheny Eye Institute, Department of Ophthalmology, David Geffen School of Medicine at University of California Los Angeles, Los Angeles, CA 90033; and.
J Immunol. 2016 Nov 15;197(10):3820-3830. doi: 10.4049/jimmunol.1600333. Epub 2016 Oct 19.
In this study, we showed that TLR7 activation significantly promoted interphotoreceptor retinoid-binding protein (IRBP)-specific Th17 responses by upregulating RORγt, IL-17, GM-CSF, and IL-23R expression in experimental autoimmune uveitis mice. In vivo administration of CL097 activated dendritic cells (DCs) and endowed them with an increased ability to activate IRBP-specific Th17 cells. CL097-treated DCs (CL097-DCs) formed a cytokine milieu that favored the generation and maintenance of Th17 cells by stimulating IL-1β, IL-6, and IL-23 expression. Furthermore, IRBP-specific T cells from immunized mice injected with CL097-DCs produced more IL-17 and transferred more severe experimental autoimmune uveitis than did those from mice injected with DCs. The enhanced immunostimulatory activities of CL097-DCs depended on JNK, ERK, and p38 activation. Blockade of ERK, but not p38 or JNK, completely abolished the Th17 responses induced by CL097-DCs. Collectively, our findings suggest that CL097 treatment significantly promotes autoreactive IL-17 T cell responses through enhancing DC activation, which is mediated, at least in part, via the activation of ERK signaling.
在本研究中,我们发现,在实验性自身免疫性葡萄膜炎小鼠中,Toll样受体7(TLR7)激活通过上调维甲酸受体相关孤儿受体γt(RORγt)、白细胞介素-17(IL-17)、粒细胞-巨噬细胞集落刺激因子(GM-CSF)和白细胞介素-23受体(IL-23R)的表达,显著促进光感受器间类视黄醇结合蛋白(IRBP)特异性Th17反应。体内给予CL097可激活树突状细胞(DC),并赋予它们更强的激活IRBP特异性Th17细胞的能力。经CL097处理的DC(CL097-DC)形成了一种细胞因子环境,通过刺激IL-1β、IL-6和IL-23的表达,有利于Th17细胞的产生和维持。此外,与注射DC的小鼠相比,注射CL097-DC的免疫小鼠中IRBP特异性T细胞产生更多的IL-17,并导致更严重的实验性自身免疫性葡萄膜炎。CL097-DC增强的免疫刺激活性依赖于JNK、ERK和p38的激活。阻断ERK而非p38或JNK,可完全消除CL097-DC诱导的Th17反应。总体而言,我们的研究结果表明,CL097治疗通过增强DC激活,显著促进自身反应性IL-17 T细胞反应,这至少部分是通过ERK信号通路的激活介导的。